Stephan Bartels

Overview

Explore the profile of Stephan Bartels including associated specialties, affiliations and a list of published articles.

Snapshot

Articles 41

Citations 311

Followers 0

Related Specialties

Pathology

Molecular Biology

Oncology

Top 10 Co-Authors

Ulrich Lehmann

Hans Kreipe

Matthias Christgen

Elisa Schipper

Henriette Christgen

Isabel Grote

Guntram Busche

Britta Hasemeier

Jerome Schlue

Oleg Gluz

Published In

J Pathol Clin Res

Virchows Arch

Mod Pathol

Cancer Med

J Mol Diagn

Affiliations

Soon will be listed here.

Recent Articles

11.

Evaluation of the routine use of E-cadherin immunohistochemistry in the typing of breast carcinomas: results of a randomized diagnostic study

Cserni G, Kalman E, Udvarhelyi N, Papp E, Grote I, Bartels S, et al.

Histopathology . 2023 Aug; 83(5):810-821. PMID: 37609779

Aims: Invasive lobular carcinoma (ILC) has distinct morphology and association with loss of E-cadherin function. It has special clinical and imaging features, and its proper recognition is important. Following a...

12.

Optimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast Carcinoma

Sflomos G, Schaumann N, Christgen M, Christgen H, Bartels S, Kreipe H, et al.

Cancers (Basel) . 2023 Jul; 15(13). PMID: 37444409

Invasive lobular carcinoma (ILC) is a common breast cancer subtype that is often diagnosed at advanced stages and causes significant morbidity. Late-onset secondary tumor recurrence affects up to 30% of...

13.

Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types

Bartels S, Grote I, Wagner M, Boog J, Schipper E, Reineke-Plaass T, et al.

Cancer Med . 2023 Jun; 12(16):16707-16715. PMID: 37376830

Background: Microsatellite instability (MSI) occurs in several cancer types and is commonly used for prognosis and as a predictive biomarker for immune checkpoint therapy. Methods: We analyzed n = 263...

14.

p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine Resistance

Mueller S, Grote I, Bartels S, Kandt L, Christgen H, Lehmann U, et al.

Mod Pathol . 2023 Feb; 36(4):100100. PMID: 36788081

TP53 mutation is associated with primary endocrine resistance in luminal breast cancer (BC). Nuclear accumulation of p53, as determined by immunohistochemistry (IHC), is a surrogate marker for TP53 mutation. The...

15.

First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma

Neumann O, Lehmann U, Bartels S, Pfarr N, Albrecht T, Ilm K, et al.

J Pathol Clin Res . 2023 Jan; 9(2):100-107. PMID: 36635225

Intrahepatic cholangiocarcinoma harbours druggable genetic lesions including FGFR2 gene fusions. Reliable and accurate detection of these fusions is becoming a critical component of the molecular work-up, but real-world data on...

16.

ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer

Grote I, Bartels S, Christgen H, Radner M, Gronewold M, Kandt L, et al.

Mod Pathol . 2022 Jul; 35(12):1804-1811. PMID: 35842479

Invasive lobular breast cancer (ILC) is a special breast cancer (BC) subtype and is mostly hormone receptor (HR)-positive and ERBB2 non-amplified. Endocrine therapy restrains tumor proliferation and is the mainstay...

17.

Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma

Christgen M, Kandt L, Antonopoulos W, Bartels S, Van Bockstal M, Bredt M, et al.

J Pathol Clin Res . 2021 Dec; 8(2):191-205. PMID: 34889530

Invasive lobular breast carcinoma (ILC) is the second most common breast carcinoma (BC) subtype and is mainly driven by loss of E-cadherin expression. Correct classification of BC as ILC is...

18.

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer

Grote I, Bartels S, Kandt L, Bollmann L, Christgen H, Gronewold M, et al.

Cancer Med . 2021 Nov; 10(23):8581-8594. PMID: 34779146

Background: Whereas the genomic landscape of endocrine-resistant breast cancer has been intensely characterized in previously treated cases with local or distant recurrence, comparably little is known about genomic alterations conveying...

19.

[Angle stable plate for treatment for insufficiency fractures of the pelvis (minimally invasive posterior locked compression plate) : Video article]

Schmerwitz I, Jungebluth P, Bartels S, Hockertz T

Unfallchirurg . 2021 Jul; 124(8):680-684. PMID: 34236449

Objective Of Surgery: High primary stability of the pelvic girdle with full weight bearing. Indications: Instability and immobility in patients with osteoporotic fractures of the pelvis. Contraindications: Decubitus ulcers, infections....

20.

Genome-wide DNA methylation profiling is able to identify prefibrotic PMF cases at risk for progression to myelofibrosis

Lehmann U, Stark H, Bartels S, Schlue J, Busche G, Kreipe H

Clin Epigenetics . 2021 Feb; 13(1):28. PMID: 33541399

Background: Patients suffering from the BCR-ABL1-negative myeloproliferative disease prefibrotic primary myelofibrosis (pre-PMF) have a certain risk for progression to myelofibrosis. Accurate risk estimation for this fibrotic progression is of prognostic...